Active Ingredient: ADAPALENE
Proprietary Name: DIFFERIN
Dosage Form; Route of Administration: SOLUTION; TOPICAL
Strength: 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020338
Product Number: 001
Approval Date: May 31, 1996
Applicant Holder Full Name: GALDERMA LABORATORIES LP
Marketing Status:
Discontinued
Patent and Exclusivity Information